Editorial Comment

J Urol. 2018 Dec;200(6):1262-1263. doi: 10.1016/j.juro.2018.06.087. Epub 2018 Aug 24.

Authors

Bernhard J Eigl¹, Nawaid Usmani²

Affiliations

¹ BC Cancer, Vancouver, British Columbia, Canada.
² Cross Cancer Institute, Edmonton, Alberta, Canada.

PMID: 30149012
DOI: 10.1016/j.juro.2018.06.087

No abstract available

Publication types

Comment

MeSH terms

Androgen Antagonists
Humans
Male
Metformin*
Prostatic Neoplasms*

Substances

Androgen Antagonists
Metformin